Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Clinical Orthopaedics and Related Research|January 14, 2017
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?Florian Posch, Lukas Leitner, Marko Bergovec, et al.
Onkologie|September 15, 2010
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodiesJoanna Szkandera, Ferdin Ploner, Thomas Bauernhofer, et al.
Breast Cancer Research and Treatment|July 20, 2007
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" studyUwe Langsenlehner, Gerald Wolf, Tanja Langsenlehner, et al.
Cancer Epidemiology|November 6, 2013
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patientsJoanna Szkandera, Gudrun Absenger, Bernadette Liegl-Atzwanger, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Oncotarget|September 28, 2014
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancerAnna Lena Ress, Verena Stiegelbauer, Daniela Schwarzenbacher, et al.
Therapeutic Advances in Medical Oncology|September 14, 2020
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRCDaniela Bianconi, Merima Herac, Florian Posch, et al.
Pageof 16